-
1
-
-
0036787219
-
Toward better early-phase brain tumor clinical trials: A reappraisal of current methods and proposals for future strategies
-
Lang FF, Gilbert MR, Puduvalli VK, et al. Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies. Neuro Oncol. 2002;4(4):268-277.
-
(2002)
Neuro Oncol
, vol.4
, Issue.4
, pp. 268-277
-
-
Lang, F.F.1
Gilbert, M.R.2
Puduvalli, V.K.3
-
2
-
-
77952317096
-
Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide
-
Polley MY, Lamborn KR, Chang SM, et al. Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide. Neuro Oncol. 2010;12(3):274-282.
-
(2010)
Neuro Oncol.
, vol.12
, Issue.3
, pp. 274-282
-
-
Polley, M.Y.1
Lamborn, K.R.2
Chang, S.M.3
-
3
-
-
34047238978
-
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme
-
DOI 10.1215/15228517-2006-025
-
Ballman KV, Buckner JC, Brown PD, et al. The relationship between sixmonth progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. Neuro Oncol. 2007;9(1):29-38. (Pubitemid 46543486)
-
(2007)
Neuro-Oncology
, vol.9
, Issue.1
, pp. 29-38
-
-
Ballman, K.V.1
Buckner, J.C.2
Brown, P.D.3
Giannini, C.4
Flynn, P.J.5
LaPlant, B.R.6
Jaeckle, K.A.7
-
4
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
DOI 10.1056/NEJMoa043330
-
Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996. (Pubitemid 40349501)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.10
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
Van Den Bent, M.J.3
Weller, M.4
Fisher, B.5
Taphoorn, M.J.B.6
Belanger, K.7
Brandes, A.A.8
Marosi, C.9
Bogdahn, U.10
Curschmann, J.11
Janzer, R.C.12
Ludwin, S.K.13
Gorlia, T.14
Allgeier, A.15
Lacombe, D.16
Cairncross, J.G.17
Eisenhauer, E.18
Mirimanoff, R.O.19
-
5
-
-
0025281789
-
Response criteria for phase II studies of supratentorial malignant glioma
-
Macdonald DR, Cascino TL, Schold SC, Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8(7):1277-1280. (Pubitemid 20195640)
-
(1990)
Journal of Clinical Oncology
, vol.8
, Issue.7
, pp. 1277-1280
-
-
Macdonald, D.R.1
Cascino, T.L.2
Schold Jr., S.C.3
Cairncross, J.G.4
-
6
-
-
77951625266
-
Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group
-
Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010;28(11):1963-1972.
-
(2010)
J Clin Oncol.
, vol.28
, Issue.11
, pp. 1963-1972
-
-
Wen, P.Y.1
MacDonald, D.R.2
Reardon, D.A.3
-
7
-
-
64649085454
-
Pseudoprogression and pseudoresponse: Challenges in brain tumor imaging
-
Review
-
Clarke JL, Chang S. Pseudoprogression and pseudoresponse: challenges in brain tumor imaging. Curr Neurol Neurosci Rep. 2009;9(3):241-246. Review.
-
(2009)
Curr Neurol Neurosci Rep
, vol.9
, Issue.3
, pp. 241-246
-
-
Clarke, J.L.1
Chang, S.2
-
8
-
-
74049087788
-
Pseudoprogression and pseudoresponse in the treatment of gliomas
-
Brandsma D, van den Bent MJ. Pseudoprogression and pseudoresponse in the treatment of gliomas. Curr Opin Neurol. 2009;22(6): 633-638.
-
(2009)
Curr Opin Neurol
, vol.22
, Issue.6
, pp. 633-638
-
-
Brandsma, D.1
Van Den Bent, M.J.2
-
9
-
-
42649106522
-
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
-
DOI 10.1016/S1470-2045(08)70125-6, PII S1470204508701256
-
Brandsma D, Stalpers L, Taal W, et al. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9(5):453-461. (Pubitemid 351597795)
-
(2008)
The Lancet Oncology
, vol.9
, Issue.5
, pp. 453-461
-
-
Brandsma, D.1
Stalpers, L.2
Taal, W.3
Sminia, P.4
Van Den Bent, M.J.5
-
10
-
-
43749094544
-
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
-
Brandes AA, Franceschi E, Tosoni A, et al. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol. 2008;26(13):2192-2197.
-
(2008)
J Clin Oncol
, vol.26
, Issue.13
, pp. 2192-2197
-
-
Brandes, A.A.1
Franceschi, E.2
Tosoni, A.3
-
11
-
-
0018633855
-
The morphologic effects of radiation administered therapeutically for intracranial gliomas. A postmortem study of 25 cases
-
DOI 10.1002/1097-0142(197910)44:4<1256::AID-CNCR2820440415>3.0. CO;2-T
-
Burger PC, Mahley MS, Jr, Dudka L, Vogel FS. The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer. 1979;44(4): 1256-1272. (Pubitemid 10197395)
-
(1979)
Cancer
, vol.44
, Issue.4
, pp. 1256-1272
-
-
Burger, P.C.1
Mahaley Jr., M.S.2
Dudka, L.3
Vogel, F.S.4
-
12
-
-
0028939011
-
Radiation necrosis or glioma recurrence: Is computer-assisted stereotactic biopsy useful?
-
Forsyth PA, Kelly PJ, Cascino TL, et al. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful? J Neurosurg. 1995;82(3):436-444.
-
(1995)
J Neurosurg
, vol.82
, Issue.3
, pp. 436-444
-
-
Forsyth, P.A.1
Kelly, P.J.2
Cascino, T.L.3
-
13
-
-
33645575773
-
Cancer therapy-associated CNS neuropathology: An update and review of the literature
-
Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol. 2006; 111(3):197-212.
-
(2006)
Acta Neuropathol
, vol.111
, Issue.3
, pp. 197-212
-
-
Perry, A.1
Schmidt, R.E.2
-
14
-
-
84859098891
-
Pathologic diagnosis of recurrent glioblastoma: Morphologic, immunohistochemical, and molecular analysis of 20 paired cases
-
Kim JH, Kim YB, Han JH, et al. Pathologic Diagnosis of Recurrent Glioblastoma: Morphologic, Immunohistochemical, and Molecular Analysis of 20 Paired Cases. Am J Surg Pathol. 2012;36(4):620-628.
-
(2012)
Am J Surg Pathol.
, vol.36
, Issue.4
, pp. 620-628
-
-
Kim, J.H.1
Kim, Y.B.2
Han, J.H.3
-
15
-
-
33244476044
-
Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: Should pathology evaluation alter treatment decisions?
-
DOI 10.1016/j.humpath.2005.11.010, PII S004681770500657X
-
Tihan T, Barletta J, Parney I, et al. Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: should pathology evaluation alter treatment decisions? Hum Pathol. 2006;37(3):272-282. (Pubitemid 43277515)
-
(2006)
Human Pathology
, vol.37
, Issue.3
, pp. 272-282
-
-
Tihan, T.1
Barletta, J.2
Parney, I.3
Lamborn, K.4
Sneed, P.K.5
Chang, S.6
-
16
-
-
76749097367
-
Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility- weighted contrast-enhanced perfusion MR imaging
-
Barajas RF, Jr, Chang JS, Segal MR, et al. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology. 2009;253(2): 486-496.
-
(2009)
Radiology
, vol.253
, Issue.2
, pp. 486-496
-
-
Barajas Jr., R.F.1
Chang, J.S.2
Segal, M.R.3
-
17
-
-
0034064281
-
Posttherapeutic intraaxial brain tumor: The value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue
-
Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrastenhancing tissue. AJNR Am J Neuroradiol. 2000;21(5):901-909. (Pubitemid 30262837)
-
(2000)
American Journal of Neuroradiology
, vol.21
, Issue.5
, pp. 901-909
-
-
Sugahara, T.1
Korogi, Y.2
Tomiguchi, S.3
Shigematsu, Y.4
Ikushima, I.5
Kira, T.6
Liang, L.7
Ushio, Y.8
Takahashi, M.9
-
18
-
-
77956132723
-
Posttreatment high-grade glioma: Usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence
-
Kim HS, Kim JH, Kim SH, et al. Posttreatment high-grade glioma: usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence. Radiology. 2010; 256(3):906-915.
-
(2010)
Radiology.
, vol.256
, Issue.3
, pp. 906-915
-
-
Kim, H.S.1
Kim, J.H.2
Kim, S.H.3
-
19
-
-
45149091277
-
Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps
-
Emblem KE, Nedregaard B, Nome T, et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology. 2008;247(3):808-817.
-
(2008)
Radiology
, vol.247
, Issue.3
, pp. 808-817
-
-
Emblem, K.E.1
Nedregaard, B.2
Nome, T.3
-
20
-
-
62649103363
-
Posttreatment recurrence of malignant brain neoplasm: Accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction
-
Gasparetto EL, Pawlak MA, Patel SH, et al. Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction. Radiology. 2009;250(3):887-896.
-
(2009)
Radiology
, vol.250
, Issue.3
, pp. 887-896
-
-
Gasparetto, E.L.1
Pawlak, M.A.2
Patel, S.H.3
-
21
-
-
64649101485
-
Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: Direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements
-
Hu LS, Baxter LC, Smith KA, et al. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol. 2009;30(3):552-558.
-
(2009)
AJNR Am J Neuroradiol
, vol.30
, Issue.3
, pp. 552-558
-
-
Hu, L.S.1
Baxter, L.C.2
Smith, K.A.3
-
22
-
-
33748084051
-
Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not
-
Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol. 2006;27(4):859-867. (Pubitemid 44897737)
-
(2006)
American Journal of Neuroradiology
, vol.27
, Issue.4
, pp. 859-867
-
-
Boxerman, J.L.1
Schmainda, K.M.2
Weisskoff, R.M.3
-
23
-
-
56149097774
-
Comparison of dynamic susceptibilityweighted contrast-enhanced MR methods: Recommendations for measuring relative cerebral blood volume in brain tumors
-
Paulson ES, Schmainda KM. Comparison of dynamic susceptibilityweighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology. 2008;249(2):601-613.
-
(2008)
Radiology
, vol.249
, Issue.2
, pp. 601-613
-
-
Paulson, E.S.1
Schmainda, K.M.2
-
24
-
-
75749125421
-
Optimized preload leakagecorrection methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas
-
Hu LS, Baxter LC, Pinnaduwage DS, et al. Optimized preload leakagecorrection methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas. AJNR Am J Neuroradiol. 2010;31(1):40-48.
-
(2010)
AJNR Am J Neuroradiol.
, vol.31
, Issue.1
, pp. 40-48
-
-
Hu, L.S.1
Baxter, L.C.2
Pinnaduwage, D.S.3
-
25
-
-
0033950756
-
Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: A possible marker of vascular tortuosity
-
DOI 10.1002/(SICI)1522-2586(200002)11:2<103::AID-JMRI5>3.0.CO;2-Z
-
Kassner A, Annesley DJ, Zhu XP, et al. Abnormalities of the contrast recirculation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity. J Magn Reson Imaging. 2000;11(2):103-113. (Pubitemid 30080962)
-
(2000)
Journal of Magnetic Resonance Imaging
, vol.11
, Issue.2
, pp. 103-113
-
-
Kassner, A.1
Annesley, D.J.2
Zhu, X.P.3
Li, K.L.4
Kamaly-Asl, I.D.5
Watson, Y.6
Jackson, A.7
-
26
-
-
84862835110
-
-
World Health Organization 4th ed. Geneva, Switzerland: World Health
-
World Health Organization. ICD-O:WHO Classification of Tumors, 4th ed. Geneva, Switzerland: World Health; 2006.
-
(2006)
ICD-O:WHO Classification of Tumors
-
-
-
27
-
-
0036820488
-
Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis
-
discussion 919-20
-
Rock JP, Hearshen D, Scarpace L, et al. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery. 2002;51(4):912-919; discussion 919-20.
-
(2002)
Neurosurgery
, vol.51
, Issue.4
, pp. 912-919
-
-
Rock, J.P.1
Hearshen, D.2
Scarpace, L.3
-
28
-
-
2342576838
-
Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and imageguided histopathology with special attention to radiation necrosis
-
discussion 1117-9
-
Rock JP, Scarpace L, Hearshen D, et al. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and imageguided histopathology with special attention to radiation necrosis. Neurosurgery. 2004;54(5):1111-1117; discussion 1117-9.
-
(2004)
Neurosurgery
, vol.54
, Issue.5
, pp. 1111-1117
-
-
Rock, J.P.1
Scarpace, L.2
Hearshen, D.3
-
29
-
-
0037222645
-
Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect
-
McGirt MJ, Bulsara KR, Cummings TJ, et al. Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect. J Neurosurg. 2003;98(1):14-20. (Pubitemid 36050442)
-
(2003)
Journal of Neurosurgery
, vol.98
, Issue.1 SUPPL.
, pp. 14-20
-
-
McGirt, M.J.1
Bulsara, K.R.2
Cummings, T.J.3
New, K.C.4
Little, K.M.5
Friedman, H.S.6
Friedman, A.H.7
-
30
-
-
27944474903
-
Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: Characterization of spatial heterogeneity
-
Lupo JM, Cha S, Chang SM, Nelson SJ. Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol. 2005;26(6):1446-1454. (Pubitemid 43733445)
-
(2005)
American Journal of Neuroradiology
, vol.26
, Issue.6
, pp. 1446-1454
-
-
Lupo, J.M.1
Cha, S.2
Chang, S.M.3
Nelson, S.J.4
-
31
-
-
0027992961
-
Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections
-
Wesseling P, van der Laak JA, de Leeuw H, et al. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. J Neurosurg. 1994;81(6):902-909. (Pubitemid 24373471)
-
(1994)
Journal of Neurosurgery
, vol.81
, Issue.6
, pp. 902-909
-
-
Wesseling, P.1
Van Der Laak, J.A.2
De Leeuw, H.3
Ruiter, D.J.4
Burger, P.C.5
-
32
-
-
33947579576
-
Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma
-
Sadeghi N, Salmon I, Decaestecker C, et al. Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. AJNR Am J Neuroradiol. 2007;28(3):455-461. (Pubitemid 46481882)
-
(2007)
American Journal of Neuroradiology
, vol.28
, Issue.3
, pp. 455-461
-
-
Sadeghi, N.1
Salmon, I.2
Decaestecker, C.3
Levivier, M.4
Metens, T.5
Wikler, D.6
Denolin, V.7
Rorive, S.8
Massager, N.9
Baleriaux, D.10
Goldman, S.11
-
33
-
-
84862908602
-
Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma
-
Hu LS, Eschbacher JM, Dueck AC, et al. Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma. AJNR Am J Neuroradiol. 2012;33(1):69-76.
-
(2012)
AJNR Am J Neuroradiol.
, vol.33
, Issue.1
, pp. 69-76
-
-
Hu, L.S.1
Eschbacher, J.M.2
Dueck, A.C.3
-
34
-
-
77955128785
-
Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma
-
Mangla R, Singh G, Ziegelitz D, et al. Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma. Radiology. 2010;256(2): 575-584.
-
(2010)
Radiology.
, vol.256
, Issue.2
, pp. 575-584
-
-
Mangla, R.1
Singh, G.2
Ziegelitz, D.3
-
35
-
-
79960411354
-
Prospective analysis of parametric response map-derived MRI biomarkers: Identification of early and distinct glioma response patterns not predicted by standard radiographic assessment
-
Galbá n CJ, Chenevert TL, Meyer CR, et al. Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment. Clin Cancer Res. 2011;17(14):4751-4760.
-
(2011)
Clin Cancer Res.
, vol.17
, Issue.14
, pp. 4751-4760
-
-
Galbán Cj, C.1
|